Clinical Trials Logo

Cortisol Overproduction clinical trials

View clinical trials related to Cortisol Overproduction.

Filter by:
  • Active, not recruiting  
  • Page 1

NCT ID: NCT05307328 Active, not recruiting - Clinical trials for Cortisol; Hypersecretion

SPI-62 as a Treatment for Adrenocorticotropic Hormone-dependent Cushing's Syndrome

RESCUE
Start date: September 1, 2022
Phase: Phase 2
Study type: Interventional

This is a randomized, placebo-controlled, study of SPI-62 in subjects with ACTH-dependent Cushing's syndrome caused by a non-adrenal tumor. Subjects will receive each of the following 2 treatments for 24 weeks: SPI-62 and matching placebo with the option of long-term extension.